Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof

a technology of hairless protein and nucleic acids, which is applied in the direction of peptide/protein ingredients, drug compositions, genetic material ingredients, etc., can solve the problem that the complete loss of hair, known as atrichia, cannot be treated by the introduction of a new gen

Inactive Publication Date: 2009-01-01
CHRISTIANO ANGELA M
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0037]This invention further provides a method of inhibiting the transition of a hair follicle from the anagen phase to the catagen phase comprising contacting the follicle with an effective amount of the instant nucleic acid molecule or the second pharmaceutical composition.

Problems solved by technology

Lack of expression of the mouse hairless gene due to inherited mutations leads to the complete loss of hair, known as atrichia.
There are, however, conditions—inherited and acquired alike—which cannot be treated by the introduction of a new gene.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof
  • Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof
  • Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Definitions

[0046]As used herein, and unless stated otherwise, each of the following terms shall have the definition set forth below.

[0047]“Administering” shall mean administering according to any of the various methods and delivery systems known to those skilled in the art. The administering can be performed, for example, via implant, transmucosally, transdermally and subcutaneously. In the preferred embodiment, the administering is topical and preferably dermal.

[0048]“Catalytic” shall mean the functioning of an agent as a catalyst, i.e. an agent that increases the rate of a chemical reaction without itself undergoing a permanent structural change.

[0049]“Consensus sequence” shall mean a nucleotide sequence of at least two residues in length between which catalytic nucleic acid cleavage occurs. For example, consensus sequences include “A:C” and “G:U”.

[0050]“Hairless Protein” shall mean the protein encoded by the nucleotide sequence shown in FIGS. 1A-1C (SEQ ID NO:1) and having the am...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
areaaaaaaaaaaa
catalytic deoxyribonucleic acidaaaaaaaaaa
Login to View More

Abstract

The present invention provides DNAzymes and ribozymes that specifically cleave Hairless protein mRNA. The present invention also provides antisense oligonucleotides that specifically inhibit translation of Hairless Protein mRNA. The present invention also provides various methods of inhibiting the expression of Hairless Protein. Finally the invention provides pharmaceutical compositions containing the instant DNAzymes, ribozymes and antisense oligonucleotides as active ingredients.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of copending U.S. patent application Ser. No. 10 / 122,013 filed Apr. 12, 2002, which claims the benefit of priority of U.S. Provisional Application No. 60 / 283,618 filed Apr. 13, 2001, the contents of each of which are hereby incorporated by reference in their entirety.BACKGROUND OF THE INVENTIONThe Hairless Gene[0002]The hairless mouse, a frequent subject of different dermatological experiments, is characterized by hair loss that starts at the age of 14 days postpartum from the upper eyelids and progresses caudally. The process is completed by the age of 3 weeks, when the mice are entirely naked and never grow hair again (Panteleyev et al. 1998b). The phenotype results from proviral integration and consequential aberrant splicing in the mouse hairless gene. Lack of expression of the mouse hairless gene due to inherited mutations leads to the complete loss of hair, known as atrichia. Other mutations have b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/43C12N9/00C12N15/63C12P19/34C12N15/11A61P17/00A01K67/027A61K9/127A61K31/7088A61K38/00A61K47/10A61K48/00A61P17/14C12N15/09C12N15/113
CPCA61K38/00C12N2310/12C12N15/113A61P17/00A61P17/14
Inventor CHRISTIANO, ANGELA M.
Owner CHRISTIANO ANGELA M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com